Indivior Faces Setback in Cannabis Disorder Treatment Trial
Indivior PLC has encountered a significant setback in its efforts to develop a treatment for cannabis use disorder (CUD). The company’s Phase 2B clinical trial, conducted in collaboration with Aelis…